Retreatment with rituximab in 178 patients with relapsed and refractory B-cell lymphomas: A single institution case control study
The role of rituximab retreatment in relapsed B-cell lymphoma is not well known. We undertook a single center retrospective cohort study to investigate the efficacy of retreatment with rituximab with or without chemotherapy in patients with relapsed and refractory B-cell lymphomas. We only included patients treated first-line and in first progression; 178 patients were included in the study, of whom 29 had diffuse large B-cell lymphoma (DLBCL) and 28 had follicular lymphoma (FL). The overall...[Show more]
|Collections||ANU Research Publications|
|Source:||Leukemia & Lymphoma|
|01_Johnston_Retreatment_with_rituximab_in_2010.pdf||863.45 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.